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Autologous matrix-induced chondrogenesis (AMIC) has gained popularity in the treatment of osteochondral le-
sions of the talus. Previous studies have presented promising short-term results for AMIC talar osteochondral
lesion repair, a 1-step technique using a collagen type I/III bilayer matrix. The aim of the present study was to
investigate the mid-term effects. The 5-year results of a prospective cohort study are presented. All patients un-
derwent an open AMIC procedure for a talar osteochondral lesion. Data analysis included general demographic
data, preoperative magnetic resonance imaging findings, intraoperative details, and German version of the Foot
Function Index (FFI-D) scores preoperatively and at 1 and 5 years after surgery. The primary outcome variablewas
the longitudinal effect of the procedure, and the influence of various variables on the outcome was tested. Of 47
consecutive patients, 21 (45%)were included.Of the21patients, 8were female (38%) and13weremale (62%),with
amean ageof 37 15 (range 15 to62) years and abodymass indexof 26 5 (range 20 to38) kg/m2. Thedefect size
was1.4 0.9 (range0.2 to4.0) cm2. TheFFI-Ddecreased significantly frompreoperatively to1yearpostoperatively
(56  18 versus 33  25; p ¼ .003), with a further, nonsignificant decrease between the 1- and 5-year follow-up
examination (33  25 versus 24  21; p ¼ .457). Similar results were found for the FFI-D subscales of function
and pain. The body mass index and lesion size showed a positive correlation with the preoperative FFI-D overall
and subscale scores. These results showed a significant improvement in pain and function after the AMIC pro-
cedure, with a significant return to sports by the 5-year follow-up point. The greatest improvement overall was
seenwithin the first year; however, further clinical satisfaction among the patients was noticeable after 5 years.
 2017 by the American College of Foot and Ankle Surgeons. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Osteochondral lesions (OCLs) are being more frequently diagnosed vascular necrosis (3), systemic vasculopathy, acute trauma (4), chronic
owing to the better diagnostic tests available and a better awareness
of the symptoms. The intrinsic repair mechanisms are poor; thus,
good therapeutic options are needed (1,2). Nonoperative treatment
should only be considered for stage I, II, or III lesions using the Berndt
and Harty classification. Higher stage lesions show better outcomes
with operative treatment. Most likely, the causes for OCLs includersements of travel expenses and
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n College of Foot and Ankle Surgeons.microtrauma (5), endocrine or metabolic factors (6), degenerative
joint disease (7), joint malalignment (8), and genetic predisposition
(9). The primary goal of operative treatment is to restore the blood
circulation and regain joint protection most similar to the original
hyaline cartilage. The microfracture method has been a promising
therapeutic option but with the notable limitation of lesions
>150 mm2 in area or >15 mm in diameter (10,11). The aim of
microfracturing is to mobilize progenitor cells from the bone marrow
such that repair cartilage can develop to cover the defect. Bone
marrow stimulation results in mesenchymal cells from the marrow to
create a fibrocartilaginous repair tissue at the site of the lesion (12).
Lesions>150mm2 in area or>15mm indiameter require a different
treatment approach. Osteochondral autologous transplantation and
autologous chondrocyte implantation (ACI) are new therapeutic optionsThis is an open access article under the CC BY-NC-ND license (http://creativecommons.
O. Gottschalk et al. / The Journal of Foot & Ankle Surgery 56 (2017) 930–936 931for large lesions (13). Both options harvest cartilage cells from a donor
site separate from the location of the actual lesion. ACI is a 2-step pro-
cedure that is time consuming and expensive. Recently, a study by Buda
et al (14) showed no advantage for ACI compared with bone marrow-
derived cell transplantation. They also reported the preferred use of
bone marrow-derived cell transplantation compared with ACI (14).
Because of limitations, such as sacrificing healthy cartilage, multiple-
stage operations, the high cost, and limited graft availability, alterna-
tive methods to repair OCLs are needed. Autologous matrix-induced
chondrogenesis (AMIC) meets this need by addressing the limitations
of other OCL repair methods. AMIC was first described in 1999 by Beh-
rens et al (15) and uses a collagen type I/III bilayer matrix (Chondro-
Gide; Geistlich Pharma AG, Wolhusen, Switzerland) to stabilize the
super clot on top of the lesion after microfracturing (16). In AMIC, the
matrix is secured at its location using commercially available fibrin glue.
After microfracture, mesenchymal progenitor cells migrate toward and
adhere to the porous layer of the matrix. With the matrix in place, the
loss of cells through leakage into the joint space can be avoided. Also,
mechanical stress on the cells in the regeneration zone will be mini-
mized. The combined use of the AMIC matrix and the fibrin glue (Tis-
sucol or Tisseel; Baxter Healthcare, Deerfield, IL) support the
chondrogenic differentiation of human mesenchymal stem cells and
significantly enhance proteoglycan deposition (17,18).
Although fibrin glue has been used in surgical procedures for more
than a decade, serving a variety of purposes, such as sutureless closure
of colonic defects (19), corneal lamellar healing (20), bone repair
(21,22), and reconstruction of focal cartilage defects (23), its use is not
without controversy. A study by Filardo et al (24) showed improve-
ment in postoperative scaffold stability and integrity using fibrin glue.
Wang et al (25), however, reported that a bone matrix gelatin and
fibrin glue scaffold showed signs of degradation after 8 weeks despite
the presence of supporting chondrocyte attachment, proliferation,
and biosynthesis of cartilaginous matrix components. Another study
proposed that fibrin sealant supports the migration and proliferation
of human chondrocytes via thrombin (26).
Although the AMIC procedure seems to have a beneficial effect on
OCLs of the talus, diverse results of microfracture and AMIC use have
been presented. In a sheep model, Beck et al (27) used a different
collagen membrane and showed bone cyst formation after micro-
fracturing with a communication present between the drilling holes
and the cysts. Another study, by Zhang et al (28), demonstrated with a
short-term follow-up period that the clinical symptoms had signifi-
cantly improved. Specifically, magnetic resonance imaging (MRI)
showed that defect coverage of the lesion of 75%, with hyaline-like
cartilage tissue, was achieved (28).
The different approaches available to examine the effect of AMIC
outcomes have been of recent interest. New studies have reported
good results for all arthroscopic uses of AMIC (29,30). MRI examina-
tion of AMIC-treated patients during a short-term follow-up period
showed differences in the collagen matrix and cartilage present (31),
with lower glycosaminoglycan content than present in normal hya-
line cartilage (32). In patients with high function demands and the
need for pain-free joints, such as athletes and patients with increased
activity levels, AMIC intervention has provided good results (33,34).
Therefore, the aim of our study was to investigate the mid-term
outcomes at the 5-year follow-up point on pain and function in pa-
tients who had undergone the AMIC procedure.Fig. 1. Preoperative magnetic resonance image, sagittal view, of medial osteochondral
lesion.Patients and Methods
Study Design
We performed a cohort study from a single specialized orthopedic foot and ankle
clinic using prospective 5-year follow-up data. The institutional review board approved
the present study. Patients were included after providing informed consent.Patients
Of 47 consecutive patients undergoing an open AMIC procedure for a talar OCL
withoutmalleolar osteotomy from June 2010 to December 2011, 21 (45%) were included
in the study cohort. The exclusion criteriawere generalized degenerative changes in the
joint, cartilage defects in the corresponding opposite joint surface, inflammatory joint
disease, crystal arthropathy, neuroarthropathy, or 5-year follow-up data missing.
Surgical Technique
Preoperative MRI scans of the ankle were used for assessment of cartilage lesions,
possible subchondral cysts, areas of necrotic bone, and other accompanying pathologic
entities (Figs. 1 and 2).
In all patients, the skin incisionwas performed using a ventral approach, depending
on the location of the defect (either a ventromedial approach between the medial
malleolus and the anterior tibial tendon or a ventrocentral approach between the
anterior tibial and the extensor hallucis longus tendon). After dissection to the level of
the joint capsule, the joint was opened by a longitudinal incision. A 2.0-mm Kirschner
wirewas drilled into the distal tibia and a second one parallel to it in the talus. Unstable
cartilage was radically debrided. All necrotic bone was removed, and any cysts were
curetted (Fig. 3). The underlying sclerotic zonewas perforated using multiple small drill
holes (1.2-mm Kirschner wire) with adequate cooling or microfracture. The osseous
defect was reconstructed to the level of the subchondral bone lamella using autologous
cancellous bone.
The defect size was measured with the help of aluminum foil, which was pressed
into the defect with forceps such that the borders of the cartilage were clearly depicted.
The aluminum foil was then cut to size and its exact fit was verified. The collagen
matrix, hydrated in a physiologic saline solution, was cut to shape with the help of the
template. When hydrated, the matrix expands by 10% to 15%. The matrix has a rough
side, which was placed facing the bone, with the smooth side facing the joint. The
cancellous bone graft was covered with commercially available fibrin glue, and the
collagen matrix was glued onto it (Fig. 4).
Finally, the joint was closed in layers using resorbable suture material. A drain
without suction was inserted, when necessary.
Postoperative Management
The operated ankle was completely immobilized at 90 for 48 hours. The drain, if
inserted, was removed within the 48-hour period, and continuous passive motion
exercises, limited to the 20-0-20 range, were started. A splint was used for 2 weeks
until wound healing was complete. Partial weightbearing of 10 kg for the first 6 weeks
was advised. Thereafter, a stepwise increase inweightbearing, increasing by 10 to 15 kg
each week, up to week 12 was allowed. From week 13 onward, the patient was
permitted to incur stress from activities of daily living, cycling, and swimming. Patients
Fig. 2. Preoperative magnetic resonance image, coronal view, of medial osteochondral
lesion.
Fig. 4. Lesion after cancellous bone filling and covering with the collagen membrane.
Table 1
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in direction for 12 months.
Data Collection
Data were collected from the outpatient records and available in-house data. In
accordance with our standardized quality management policy, the patients were asked
to complete a standardized foot and ankle questionnaire (Foot Function Index, German
version [FFI-D]) (35) preoperatively and 1 year postoperatively. At the 5-year follow-up
examination, the patients were asked to again complete the FFI-D. The collected data
points of interest are listed in Table 1.
Outcome Variables
The primary outcome variable was the FFI-D score. The secondary outcome vari-
ables were the influence of age, gender, smoking, body mass index (BMI), duration of
symptoms, relationship to trauma, defect size, and defect location.
Statistical Analysis
Statistical analysis was performed using the software package SPSS, version 22
(IBM Corp., Armonk, NY). The data are presented as the mean  standard deviation.
General descriptive statistical analyses were performed. Data were compared using the
t test and repeated measurement analysis of variance (post hoc Bonferroni test).Fig. 3. Intraoperative view of the lesion.Correlations were determined by calculating the Spearman coefficient for normally
distributed values. p Values  .05 were considered to indicate statistical significance.
Results
Demographic Data
Twenty-one patients (45% of 47 consecutive patients) were
included in our analysis. The other AMIC patients were not included
owing to missing follow-up data, a change of address, or a lack of
interest. Of the 21 patients, 8 (38%) were female and 13 (62%) were
male, with amean age of 37 15 (range 15 to 62) years and an average
BMI of 26 5 (range 20 to 38) kg/m2. Themean duration of symptoms
was 54  43 (range 5 to 132) months. Of the 21 patients, 3 (14%) were
smokers; and 12 (57%) had undergone a previous ipsilateral surgical
intervention. Finally, 10 (48%) had not experienced any trauma before
the beginning of the symptoms; 2 (10%) had experienced trauma
within in the previous year; and 9 (43%) had experienced trauma
>12 months before surgery.
Preoperative MRI
All 21 patients (100%), underwent preoperative MRI. Sagittal and
coronal views were used to determine the defect size and location.





Etiology (no trauma, trauma within 12 mo, trauma >12 mo)
Preoperative MRI findings
Lesion size (cm2)








5-y Postoperative follow-up assessment
Abbreviations: BMI, body mass index; FFI-D, German version of the Foot Function In-
dex; MRI, magnetic resonance imaging.
Fig. 5. Comparison of the German version of the Foot Function Index (FFI-D) total score at
the preoperative and 1- and 5-year follow-up assessments.
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3 (14%) patients.
Intraoperative Details
Surgery was performed from June 8, 2010 to December 6, 2011.
Additional procedures, listed in Table 2, were required for 20 patients
(95%).
Subjective Outcome (FFI-D)
The FFI-D total score decreased significantly from preoperatively
to 1 year postoperatively (56  18 versus 33  25; p ¼ .003), with a
further, nonsignificant decrease between the 1- and 5-year follow-up
points (33  25 versus 24  21; p ¼ .457; Fig. 5).
Similar results were observed for the 2 FFI-D subscales of function
(Fig. 6A) and pain (Fig. 6B). Analysis of the FFI-D subscales of function
and pain revealed significant decreases from preoperatively to 1 year
postoperatively (58  18 versus 36  27, p ¼ .004; and 53  21 versus
29  24, p ¼ .003; respectively), with a further, nonsignificant
decrease between the 1- and 5-year follow-up points (36  27 versus
27  23, p ¼ .482; and 29  24 versus 21  20, p ¼ .514; respectively).
Furthermore, each item of the FFI-D at each follow-up examination
(preoperatively and 1 and 5 years postoperatively) was analyzed
separately (Supplemental Table 1). No overall significant differences
(analysis of variance) could be found for the items 2 to 8 in the pain
subscale and items 6, 7, 8, and 10 in the function subscale. For all other
items, significant overall differences were found. No significant dif-
ferences could be identified between the preoperative and 1-year
postoperative values, except for the item 1 in the pain subscale
(p ¼ .002). However, significant differences were found for all items
when comparing the preoperative and 5-year follow-up scores
(p ¼ .022 to p < .001). In particular, item 9 in the FFI-D function
subscale, evaluating sports activity (Fig. 7), showed a significant
decrease between the preoperative and 5-year follow-up points
(p ¼ .013).
Factors Affecting FFI-D Scores
Gender, smoking status, previous surgical interventions, etiology
(trauma), defect location, and symptom duration had no a significant
influence on the FFI-D score or subgroup scores. Age and BMI showed
a moderate, but significant, positive correlationwith the preoperative
FFI-D and both subscale (FFI-D for pain and FFI-D for function) out-
comes analyzed (Table 3). Only the size of the lesion resulted in a
significant positive correlation with the FFI-D and subscale scores
preoperatively and at 5 years postoperatively.
MRI Findings at 5-Year Follow-Up Point
The MOCART (3-dimensional magnetic resonance observation of
cartilage repair tissue) score was used to assess the findings on theTable 2
Additional procedures performed concurrent with Autologous matrix-induced chondro-
genesis procedure (N ¼ 21 patients)
Additional Procedure Patients [n (%)]
Cancellous bone graft 16 (76.19)
Reconstruction of lateral ligaments 5 (23.81)
Neurolysis of peroneus superficialis nerve 1 (4.76)
Arthroscopy before arthrotomy 10 (47.62)
Reconstruction of peroneal tendon 2 (9.52)
Hardware removal 1 (4.76)
Lengthening of Achilles tendon 1 (4.76)
Reconstruction of syndesmosis 1 (4.76)MRI scans at the 5-year follow-up point. Local hypertrophy was found
in 60% of the patients; however, the cartilage signal showed no sig-
nificant differences compared with the surrounding cartilage. Bone
regeneration was incomplete in a great number of patients. The
subchondral lamella was intact in only 20% of the patients, and the
subchondral bones showedminimal edema in 90% of the patients. The
average MOCART score was 54  14. Further details are given in
Table 4.Discussion
Using a biomaterial, in AMIC, a collagen matrix, helps to keep and
stabilize the super clot in the defect zone and protects it from being
displaced (36,37). The collagen matrix can be implanted without
having to perform an osteotomy of the medial malleolus (38). The
collagenmatrix is available as a ready to use product with a long shelf-
life (Chondro-Gide; Geistlich Pharma AG). The membrane has been
certified in the European community for cartilage reconstruction. No
donor site is required. Compared with cartilage reconstruction with
in vitro-cultured chondrocytes, the use of the membrane results in
significantly lower selling.
The results of the present investigation showed significant
improvement in pain and function 5 years after AMIC talar OCL repair.
Several short-term studies have demonstrated good clinical and
morphologic results (16,39). However, to the best of our knowledge,
no other study has investigated the outcomes of AMIC treatment of
talar OCLs during a 5-year period. Using AMIC in other joints, how-
ever, has resulted in beneficial clinical outcomes in several studies
(40–42). One study by Fontana and de Girolama (43) reported the
mid-term results with a 5-year benefit of AMIC for femoral acetabular
impingement-induced chondral lesions compared with microfracture
treatment.
Although most patients showed a decrease in the overall FFI-D
score after 5 years, some patients still reported a pain level and
constraint of function unchanged from those preoperatively. A few
patients presented with a greater FFI-D score postoperatively than
preoperatively. This raises the question of which factors might influ-
ence the long-term outcomes with AMIC treatment. Because most
patients with talar OCLs have experienced trauma (5), it is not un-
common for patients undergoing surgery of a talar OCL to also present
with other pathologic features in the ankle. One of the reasons for the
different outcomes in clinical satisfaction might be related to the
Fig. 6. German version of the Foot Function Index (FFI-D) subscale scores for (A) function and (B) pain at the preoperative and 1- and 5-year follow-up assessments.
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using AMIC. An additional intervention such as calcaneus osteotomy
requires a prolonged recovery that is almost double the amount of
non-weightbearing. Such long recovery times also make it more
difficult for the patient to return to normal movement, mobility, and
exercise. Additional interventions will also cause additional scars,
making the soft tissue stiffer and slowing down recovery. The out-
comes with AMIC will be influenced in a high percentage of cases by
the additional interventions required. Some of our patients also pre-
sented with subdiagnoses, which can intervene with recovery and
thus influence the clinical outcomes. In contrast, Woelfle et al (44)
reported that only the age influenced the outcome, with no other
factors such as BMI > 25 kg/m2, preexisting osteoarthritis, or failed
previous surgery affecting the outcome. Elderly patients are also more
prone to develop physical limitations such as ipsilateral hip or knee
osteoarthritis, which can influence patient satisfaction of OCL repair
in the ankle.
Patients’ ability to return to normal or even increased sports ac-
tivity after surgery could also be a factor influencing the different
satisfaction rates. Although some patients undergoing osteochondral
transplantation of the talus were able to return to sports activity at an
equal level compared with preoperatively when performing low- orFig. 7. German version of the Foot Function Index (FFI-D) item for sports activity at the
preoperative and 1- and 5-year follow-up assessments.mid-level activities, some of the patients changed their sporting ac-
tivity. Wiewiorski et al (34) reported that the percentage of patients
involved in sporting activities before the onset of symptoms had
become significantly lower at the time of surgery, which differs from
our findings regarding patients return to sporting activity. No signif-
icant difference in the weekly sports frequency and the duration of
sports activity was found postoperatively. Considering the different
sports and the results, high-impact and contact sports seemed to have
the most negative outcomes (34,45).
Further studies comparing all-arthroscopic AMIC and open proced-
ures might show additional improvement, allowing patients to return
more quickly to normal activity, which could also result from the lesser
formation of scar tissue. To date, studies investigating all-arthroscopic
AMIC have shown good clinical and radiologic results (30). However,
the open procedure should be reserved for lesions reaching a certain
size, especially those with subchondral cyst formation.
Even at the final follow-up examination, the number of abnor-
malities seen on the MRI scans was high. Ninety percent of our pa-
tients still had some local edema of the subchondral bone and
irregularities of the subchondral lamella. Kubosch et al (39) recently
reported a study of MRI after AMIC. They also found persistent bone
edema in a high percentage of patients, with a cartilage signal of the
reconstructed tissue that showed no significant differences compared
with the surrounding cartilage.
The FFI-D subgroups include a variety of questions for patients to
evaluate their pain and function during the previous week. Some ofTable 3
Correlation of age, body mass index, lesion size, and symptom duration with German
version of Foot Function Index scores (N ¼ 21 patients)
Variable FFI Score at t0 FFI Score at t1 FFI Score at t5




0.656 0.542 0.636 0.291 0.250 0.271 0.407 0.393 0.411




0.618 0.506 0.600 0.119 0.106 0.113 0.297 0.339 0.326




0.536 0.448 0.520 0.469 0.465 0.472 0.561 0.544 0.568
p Value .018 .055 .023 .058 .060 .056 .012 .016 .011
Abbreviations: BMI, body mass index; FFI-D, German version of Foot Function Index;
t0, preoperatively; t1, 1 year postoperatively; t5, 5 years postoperatively.
Bold indicates p values  0.05.
Table 4
Three-dimensional magnetic resonance observation of cartilage repair tissue score at
5-year follow-up assessment (N ¼ 21 patients)
MOCART Score Mean Value SD
Degree of defect repair 13.75 4.60
Integration of border zone 10.25 3.61
Surface of repair tissue 6.25 3.04
Structure of repair tissue 2 2.39
Signal intensity PDW-TSE 6.5 6.38
Signal intensity 3D GRE 7.25 6.45
Subchondral lamina 1 1.95
Subchondral bone 0.75 1.74
Adhesions 5 0
Effusion 1.5 2.24
Abbreviations: 3D GRE, 3-dimensional gradient recalled echo; MOCART, Three-
dimensional magnetic resonance observation of cartilage repair tissue; PDW-TSE,
proton density-weighted turbo spin echo; SD, standard deviation.
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developed in the ankle joint. These items include night pain and
“leaving the house” as major factors for participating in a social life.
Importantly, our findings showed that the worst pain decreased
significantly after an AMIC procedure and was maintained during the
follow-up period.
Although some might believe that using the FFI would result in
limitations, especially during the mean study period of 5 years, a
study by Naal et al (35) proved the good reliability and validity of the
FFI for the self-assessment of pain and disability in German-speaking
patients without rheumatoid disease but with foot complaints.
Most of the demographic data analyzed in the present study did
not show effects on the FFI-D outcomes. One possible reasonmight be
the small number of patients studied. However, patient question-
naires also include the patient’s expectations, which is likely to differ
between those older and younger. It is widely known that smoking
has a negative effect on the healing process and wound healing
(46,47). Therefore, the low number of 2 patients smoking in our study
should generally be considered good but the number of patients was
not representative enough to result in an effect.
The BMI is a good factor that relates to the patients’ activity level.
Thus, the correlation found preoperatively was not surprising andwas
in accordancewith published data showing that a lower BMI results in
better clinical outcomes (48). The duration of symptoms did not seem
to influence the clinical outcomes, which could contrast with the idea
of pain memory; therefore, a reduced outcome, especially for the FFI-
D pain subscale, would be expected.
The location of the lesion also did not have an effect on the
outcome. Thus, a medial, lateral, or central location for an OCL is
secondary to the lesion size. Previous studies have shown that the size
of a lesion influences the outcome, as does the operative procedure
chosen (13,49,50). The reason we did not see an influence from the
OCL location compared with recent findings from Polat et al (51)
might have been related to the small number of lateral lesions (14%)
in our patients and the aggressive treatment of adjacent pathologic
features such as instability.
In the case of incomplete healing of the bone graft with renewed
cyst formation (52), it is possible to repeat the intervention. However,
after surgical failure, it is important to reassess the possible me-
chanical causes such as axial malalignment or instability, which
should be addressed in any type of revision surgery.
The limitations of our study were as follows. The final follow-up
proportion was 45%. This limited follow-up proportion is a clear
limitation of our study. The heterogeneity of the patient sample was
also a limitation. More than 50% of the patients had experienced
trauma before surgery, some had undergone previous surgery, and
>90% had undergone additional surgical procedures concurrent withAMIC. Finally, the preoperative work status and level of activity was
unknown. Consequently, we were unable to report any correlation
between the activity level and the outcomes. However, the FFI-D
subscale function items 8 and 9 measure the patient’s return to fast
walking or running and hobbies and sports activities, respectively.
Although the FFI-D is a good and reliable questionnaire, it includes
limitations to a complete and diverse investigation of the clinical out-
comes. The FFI-D represents a 1-week retrospective by the patient,
which might have been an especially poor or good week for the indi-
vidual patient. Another bias could also be the period in which the pa-
tient shouldbestbeable to remember theiranswers from5years earlier
to appropriately compare their answers at 3 different time points.
In conclusion, to the best of our knowledge, we have reported for
the first time the follow-up data for clinical parameters using the FFI-
D during a 5-year study period. Our results showed that the greatest
improvement occurs within the first year after the surgery, as shown
by the significant decrease in the FFI-D scores. Even after a 5-year
period, further improvement could be seen. Different parameters
seemed to have an effect on the clinical outcomes, with the lesion size
having a major role.Supplementary Material
Supplementary material associated with this article can be found
in the online version at www.jfas.org (http://dx.doi.org/10.1053/j.jfas.
2017.05.002).References
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